Dr. Mayur Miruliya Consultant, Medical Oncology
Biography
Dedicated and compassionate Medical Oncologist with comprehensive training in the diagnosis and management of solid tumors and hematological malignancies. Recognized for academic excellence with multiple university gold medals and a strong commitment to evidence-based, patient-centered cancer care. Experienced in administering chemotherapy, immunotherapy, targeted therapy, and hormonal therapy, with active involvement as a Sub-Investigator in multinational Phase I-III oncology clinical trials. Skilled in multidisciplinary tumor board discussions, scientific writing, postgraduate teaching, and clinical research. Passionate about delivering high-quality oncology care through collaboration, innovation, and continuous learning.
Areas of Expertise
- Management of Solid Tumors and Hematological Malignancies
- Chemotherapy Administration
- Immunotherapy
- Targeted Therapy
- Hormonal Therapy
- Oncologic Emergency Management
- Multidisciplinary Tumor Board Participation
- Cancer Staging and Guideline-Based Treatment Planning
- Clinical Research and Trial Coordination
- Scientific Writing and Medical Presentations
- Electronic Medical Records (EMR) Documentation
- Effective Patient Communication and Team Collaboration
Education and Training
- DM Medical Oncology (2023-2026) The Gujarat Cancer & Research Institute (GCRI), Ahmedabad
- MD Internal Medicine (2019-2022) B.J. Medical College, Ahmedabad
- MBBS (2013-2019) Government Medical College, Bhavnagar
Professional Work
- Senior Resident, Department of Internal Medicine 2022 (6 Months) Managed a wide spectrum of medical emergencies and complex inpatient cases while gaining extensive experience in evidence-based clinical decision-making, multidisciplinary patient care, and academic teaching.
Awards & Achievements
- First Prize, Breast Cancer Quiz, Best of SABCS, Ahmedabad (January 2025)
- Third Prize, Lung Cancer Updates Quiz, HCG Ahmedabad (January 2025)
- First prize, SCRI-CON 2025, 2nd Annual conference of SHALBY hospital & research institute.
Research & Publication
- Actively involved as a Sub-Investigator in multinational oncology clinical trials, including:
A Phase-2, Open-label, Randomized, Parallel-group, three arm, Study to Assess Efficacy and Safety of Cabazitaxel Lipid Tablet in Combination with Prednisone for the Treatment of Adult Men with Metastatic Castration-Resistant Prostate Cancer Previously Treated with a Docetaxel containing Treatment Regimen.
Prospective, single-arm, open-label, multicenter Phase I/II study evaluating the safety and efficacy of MyCART-01 in patients with CD19-positive relapsed or refractory B-cell malignancies.